BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 9261164)

  • 1. A new function for the C-terminal zinc finger of the glucocorticoid receptor. Repression of RelA transactivation.
    Liden J; Delaunay F; Rafter I; Gustafsson J; Okret S
    J Biol Chem; 1997 Aug; 272(34):21467-72. PubMed ID: 9261164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Negative cross-talk between RelA and the glucocorticoid receptor: a possible mechanism for the antiinflammatory action of glucocorticoids.
    Caldenhoven E; Liden J; Wissink S; Van de Stolpe A; Raaijmakers J; Koenderman L; Okret S; Gustafsson JA; Van der Saag PT
    Mol Endocrinol; 1995 Apr; 9(4):401-12. PubMed ID: 7659084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of mechanisms involved in transrepression of NF-kappa B by activated glucocorticoid receptors.
    Scheinman RI; Gualberto A; Jewell CM; Cidlowski JA; Baldwin AS
    Mol Cell Biol; 1995 Feb; 15(2):943-53. PubMed ID: 7823959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The rat glucocorticoid receptor mutant K461A differentiates between two different mechanisms of transrepression.
    Meyer T; Starr DB; Carlstedt-Duke J
    J Biol Chem; 1997 Aug; 272(34):21090-5. PubMed ID: 9261112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CBP (CREB binding protein) integrates NF-kappaB (nuclear factor-kappaB) and glucocorticoid receptor physical interactions and antagonism.
    McKay LI; Cidlowski JA
    Mol Endocrinol; 2000 Aug; 14(8):1222-34. PubMed ID: 10935546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of endogenous glucocorticoid repressed genes differentially regulated by a glucocorticoid receptor mutant able to separate between nuclear factor-kappaB and activator protein-1 repression.
    Bladh LG; Lidén J; Dahlman-Wright K; Reimers M; Nilsson S; Okret S
    Mol Pharmacol; 2005 Mar; 67(3):815-26. PubMed ID: 15550679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucocorticoid ligands specify different interactions with NF-kappaB by allosteric effects on the glucocorticoid receptor DNA binding domain.
    Garside H; Stevens A; Farrow S; Normand C; Houle B; Berry A; Maschera B; Ray D
    J Biol Chem; 2004 Nov; 279(48):50050-9. PubMed ID: 15355994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repression of p65 transcriptional activation by the glucocorticoid receptor in the absence of receptor-coactivator interactions.
    Wu J; Li Y; Dietz J; Lala DS
    Mol Endocrinol; 2004 Jan; 18(1):53-62. PubMed ID: 14551261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-talk between nuclear factor-kappa B and the steroid hormone receptors: mechanisms of mutual antagonism.
    McKay LI; Cidlowski JA
    Mol Endocrinol; 1998 Jan; 12(1):45-56. PubMed ID: 9440809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two basic amino acids C-terminal of the proximal box specify functional binding of the vitamin D receptor to its rat osteocalcin deoxyribonucleic acid-responsive element.
    Hsieh JC; Whitfield GK; Jurutka PW; Haussler CA; Thatcher ML; Thompson PD; Dang HT; Galligan MA; Oza AK; Haussler MR
    Endocrinology; 2003 Nov; 144(11):5065-80. PubMed ID: 12960019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How glucocorticoid receptors modulate the activity of other transcription factors: a scope beyond tethering.
    Ratman D; Vanden Berghe W; Dejager L; Libert C; Tavernier J; Beck IM; De Bosscher K
    Mol Cell Endocrinol; 2013 Nov; 380(1-2):41-54. PubMed ID: 23267834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of heat shock transcription factor by GR.
    Wadekar SA; Li D; Periyasamy S; Sánchez ER
    Mol Endocrinol; 2001 Aug; 15(8):1396-410. PubMed ID: 11463862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repressor to activator switch by mutations in the first Zn finger of the glucocorticoid receptor: is direct DNA binding necessary?
    Ray A; LaForge KS; Sehgal PB
    Proc Natl Acad Sci U S A; 1991 Aug; 88(16):7086-90. PubMed ID: 1871124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucocorticoid receptor ligand binding domain is sufficient for the modulation of glucocorticoid induction properties by homologous receptors, coactivator transcription intermediary factor 2, and Ubc9.
    Cho S; Kagan BL; Blackford JA; Szapary D; Simons SS
    Mol Endocrinol; 2005 Feb; 19(2):290-311. PubMed ID: 15539428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct domains of the RelA NF-kappaB subunit are required for negative cross-talk and direct interaction with the glucocorticoid receptor.
    Wissink S; van Heerde EC; Schmitz ML; Kalkhoven E; van der Burg B; Baeuerle PA; van der Saag PT
    J Biol Chem; 1997 Aug; 272(35):22278-84. PubMed ID: 9268377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A hotspot in the glucocorticoid receptor DNA-binding domain susceptible to loss of function mutation.
    Banuelos J; Shin SC; Lu NZ
    Steroids; 2015 Apr; 96():115-20. PubMed ID: 25676786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of glucocorticoid receptor isoforms with transcription factors AP-1 and NF-kappaB: lack of effect of glucocorticoid receptor beta.
    Brogan IJ; Murray IA; Cerillo G; Needham M; White A; Davis JR
    Mol Cell Endocrinol; 1999 Nov; 157(1-2):95-104. PubMed ID: 10619401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of glucocorticoid receptor (GR) with estrogen receptor (ER) α and activator protein 1 (AP1) in dexamethasone-mediated interference of ERα activity.
    Karmakar S; Jin Y; Nagaich AK
    J Biol Chem; 2013 Aug; 288(33):24020-34. PubMed ID: 23814048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucocorticoid repression of inflammatory gene expression shows differential responsiveness by transactivation- and transrepression-dependent mechanisms.
    King EM; Chivers JE; Rider CF; Minnich A; Giembycz MA; Newton R
    PLoS One; 2013; 8(1):e53936. PubMed ID: 23349769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The glucocorticoid receptor inhibits NFkappaB by interfering with serine-2 phosphorylation of the RNA polymerase II carboxy-terminal domain.
    Nissen RM; Yamamoto KR
    Genes Dev; 2000 Sep; 14(18):2314-29. PubMed ID: 10995388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.